| Gene | Associated with GRANULOMATOUS DISEASE, CHRONIC in | Link to HGNC | Cytogenetic band | Number of associated diseases | Associated diseases |
|---|---|---|---|---|---|
| CYBB | ClinVar, OMIM, HUMSAVAR | HGNC link | Xp21.1 | 2 | PS306400, 300645 |
| NCF2 | ClinVar, OMIM, HUMSAVAR | HGNC link | 1q25.3 | 1 | PS306400 |
| NCF1 | ClinVar, OMIM, HUMSAVAR | HGNC link | 7q11.23 | 1 | PS306400 |
| CYBA | ClinVar, OMIM, HUMSAVAR | HGNC link | 16q24.2 | 1 | PS306400 |
| NCF4 | ClinVar, OMIM, HUMSAVAR | HGNC link | 22q12.3 | 1 | PS306400 |
Download the disease annotation in CSV format
| regulated gene | associated to this disease | # TFs | TFs | # TFs associated with this disease | TFs associated with this disease |
|---|---|---|---|---|---|
| CYBB | YES | 9 | CUX1, SPI1, IRF8, IRF1, SATB1, GATA1, EP300, GATA2, ELF1 | 0 | |
| NCF2 | YES | 5 | IRF1, MED15, SPI1, PLAGL2, IRF8 | 0 | |
| NCF1 | YES | 1 | HBP1 | 0 |
| Gene1 | Gene2 | Direct Interaction | Number of shared interactors | Shared genes in interaction |
|---|---|---|---|---|
| CYBB | NCF1 | No | 1 | ACTB |
| NCF2 | NCF1 | Yes | 7 | NCF4, PRKDC, SYTL1, CYBA, GNAI1, TRAF4, NCF1 |
| NCF2 | CYBA | Yes | 1 | NCF1 |
| NCF2 | NCF4 | Yes | 2 | PRKDC, NCF1 |
| NCF1 | CYBA | Yes | 2 | NCF2, NCF1 |
| NCF1 | NCF4 | Yes | 4 | MSN, NCF2, PRKDC, NCF1 |
| CYBA | NCF4 | No | 2 | NCF2, NCF1 |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
| Gene1 | Gene2 | Interaction | Number of common interactors | Common genes in interaction |
|---|---|---|---|---|
| NCF2 | NCF1 | Yes | 3 | NCF2, NCF4, NCF1 |
| NCF2 | CYBA | No | 1 | NCF1 |
| NCF2 | NCF4 | Yes | 3 | NCF2, NCF4, NCF1 |
| NCF1 | CYBA | Yes | 2 | CYBA, NCF1 |
| NCF1 | NCF4 | Yes | 3 | NCF2, NCF4, NCF1 |
| CYBA | NCF4 | No | 1 | NCF1 |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
| KEGG term | KEGG term ID | IC | Number of genes with the same term | Genes |
|---|---|---|---|---|
| Leukocyte transendothelial migration | hsa04670 | 5.74 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Phagosome | hsa04145 | 5.27 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Osteoclast differentiation | hsa04380 | 5.64 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Leishmaniasis | hsa05140 | 6.32 | 4 | NCF2, NCF4, CYBA, NCF1 |
| Term | New enriched term | IC | P value | Genes |
|---|---|---|---|---|
| Cellular Processes | NEW | 2.22 | 0.008 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Infectious diseases: Parasitic | NEW | 4.46 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Leishmaniasis (hsa05140) | - | 6.32 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Leukocyte transendothelial migration (hsa04670) | - | 5.74 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Phagosome (hsa04145) | - | 5.27 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Immune system | NEW | 2.92 | 0.022 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Osteoclast differentiation (hsa04380) | - | 5.64 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| HIF-1 signaling pathway (hsa04066) | NEW | 5.9 | 0.0 | CYBA, NCF2, NCF1, CYBB |
| Transport and catabolism | NEW | 3.49 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Development | NEW | 4.58 | 0.0 | CYBA, NCF2, NCF4, NCF1, CYBB |
| REACTOME term | REACTOME term ID | IC | Number of genes with the same term | Genes |
|---|---|---|---|---|
| Phagosomal maturation (early endosomal stage) | R-HSA-1222556 | 7.89 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| RHO GTPases Activate NADPH Oxidases | R-HSA-5668599 | 9.52 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| RHO GTPase Effectors | R-HSA-195258 | 4.94 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Signaling by VEGF | R-HSA-194138 | 4.66 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.88 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 9.98 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Immune System | R-HSA-168256 | 2.37 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Signaling by Rho GTPases | R-HSA-194315 | 4.43 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Infectious disease | R-HSA-5663205 | 4.47 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.65 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Disease | R-HSA-1643685 | 3.33 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Latent infection of Homo sapiens with Mycobacterium tuberculosis | R-HSA-1222352 | 7.89 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Adaptive Immune System | R-HSA-1280218 | 3.19 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |
| Signal Transduction | R-HSA-162582 | 1.78 | 5 | CYBA, NCF2, NCF4, NCF1, CYBB |